1. Home
  2. PAR vs MYGN Comparison

PAR vs MYGN Comparison

Compare PAR & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PAR Technology Corporation

PAR

PAR Technology Corporation

HOLD

Current Price

$12.92

Market Cap

887.7M

Sector

Miscellaneous

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.28

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAR
MYGN
Founded
1968
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
887.7M
481.6M
IPO Year
1995
1996

Fundamental Metrics

Financial Performance
Metric
PAR
MYGN
Price
$12.92
$4.28
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$34.20
$7.64
AVG Volume (30 Days)
2.3M
1.7M
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$455,547,000.00
$771,400,000.00
Revenue This Year
$9.82
$6.89
Revenue Next Year
$11.27
$5.35
P/E Ratio
N/A
N/A
Revenue Growth
30.16
2.33
52 Week Low
$12.47
$3.76
52 Week High
$72.15
$8.63

Technical Indicators

Market Signals
Indicator
PAR
MYGN
Relative Strength Index (RSI) 26.21 36.52
Support Level $12.47 $4.24
Resistance Level $38.02 $5.69
Average True Range (ATR) 1.01 0.32
MACD 0.14 -0.02
Stochastic Oscillator 9.65 2.96

Price Performance

Historical Comparison
PAR
MYGN

About PAR PAR Technology Corporation

PAR Technology Corp is a foodservice technology company providing omnichannel cloud-based software and hardware solutions to the restaurant industry in three restaurant categories - quick service, fast casual, and table service - and the retail industry, including convenience and fuel retailers (C-Stores). The company's product and service offerings include point-of-sale, customer engagement and loyalty, digital ordering and delivery, operational intelligence, payment processing, hardware, and related technologies, solutions, and services. The company generates revenue from subscription service, Sale of Hardware products, and Professional Service.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: